Source:http://linkedlifedata.com/resource/pubmed/id/21270603
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2011-1-28
|
| pubmed:abstractText |
Cervical cancer is the second most common cancer affecting women worldwide. It is characterized by chromosomal aberrations and alteration in the expression levels of many cell cycle regulatory proteins. MYBL2 is a member of the MYB proto-oncogene family that encodes DNA binding proteins. These proteins are involved in cell proliferation and control of cellular differentiation.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
1525-1438
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
21
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
206-12
|
| pubmed:meshHeading |
pubmed-meshheading:21270603-Cell Cycle Proteins,
pubmed-meshheading:21270603-Cell Line, Tumor,
pubmed-meshheading:21270603-Female,
pubmed-meshheading:21270603-Gene Expression Profiling,
pubmed-meshheading:21270603-Humans,
pubmed-meshheading:21270603-Trans-Activators,
pubmed-meshheading:21270603-Tumor Markers, Biological,
pubmed-meshheading:21270603-Uterine Cervical Neoplasms
|
| pubmed:year |
2011
|
| pubmed:articleTitle |
MYBL2 (B-MYB) in cervical cancer: putative biomarker.
|
| pubmed:affiliation |
Department of Morbid Anatomy and Histopathology, Trinity College Dublin, Ireland. kathastbury@gmail.com
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|